📌 Key Takeaways
- Topic: Silica Whiteness: How It Is Measured and Why It Matters for Coatings and Rubber
- Keywords: silicon dioxide chemical properties
- Published: 2026-11-20 03:04:56
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Supplier Korea: Key Producers, Demand Sectors and Import Options
- What Is Micro Silica? Properties, Specifications and Uses in Concrete and Refractories
- Li, J. et al. Amorphous ultra‐small fe‐based nanocluster engineered and ICG loaded organo‐mesoporous silica for GSH depletion and photothermal‐chemodynamic synergistic therapy. Adv. Healthc. Mater. 11, 2201986 (2022). Article CAS Google Scholar
- What Is Silicon Dioxide? Simple Definition, Formula and Everyday Examples
- Silica Nanoparticles: Synthesis, Properties, Safety and Applications
- Tamarov, K., Näkki, S., Xu, W. & Lehto, V.-P. Approaches to improve the biocompatibility and systemic circulation of inorganic porous nanoparticles. J. Mater. Chem. B 6, 3632-3649 (2018). Post CAS PubMed Google Scholar
- Fused Silica Powder: Purity, Particle Sizes, CTE and Electronic Applications
Silica 99% Purity: Specifications, Grades and Typical Applications
What is silica (SiO₂)?
Chinese fumed silica vs Aerosil Due to the essential function of MSNs in the biomedical field, the timeline of some key achievements involving MSNs is presented in Fig. 3. Comparable to MCM-41, Santa Barbara Amorphous-15 (SBA-15) is also demonstrated to be another really promising nanomaterial in the biomedical field, which is a highly stable mesoporous silica sieve reported by scientists from the University of California at Santa Barbara in 1998. 47 Several years later, the first instance of biomedical applications involving mesoporous silica for drug delivery is reported. 48 MCM-41 is revealed to have the talent to load and deliver the anti-inflammatory drug, ibuprofen, with a weight percent ratio of 30%. 48 In the same year, researchers from two different research groups both reported that the particle size of MCM-41 could be tuned to the nanoscale, 49, 50 and its morphology could also be precisely designed. 50 These findings have greatly encouraged researchers to discuss the potential biomedical applications of MSNs. In 2003, Lai et al. explored the feasibility of MCM-41-type MSNs in controlled-release delivery systems, in which they used cadmium sulfide (CdS) NPs as chemically removable caps to encapsulate drug molecules into the pore channels of MSNs. 51 Subsequently, the disulfide bond-reducing molecules served as triggers to control the stimuli-responsive release of drug molecules including vancomycin and adenosine triphosphate. 51 In the meantime, the same research group also utilized polyamidoamines to modify the surface of MCM-41-type MSNs, and constructed a novel gene transfection system in 2004, which is the first study of the uptake behavior about MSNs into the eukaryotic cells. 52 Afterwards, Lin et al. developed fluorescein-labelled hexagonal crystal-like MSNs with a size of 110 nm as cell marker. 53 To fully exploit the physicochemical properties of MSNs and their potential for biomedical applications, in 2008, Liong et al. loaded superparamagnetic iron oxide into the internal pores of MSNs and subjected MSNs to phosphonate coating, targeting ligand modification and anti-cancer drug encapsulation, resulting in a multifunctional silica-based nanoplatform that can be used for imaging, targeting and drug delivery. 54 Since the degradability of MSNs is critical to the growth of nanoformulations with high safety, researchers continue to discuss the degradation behavior and mechanisms of MSNs. In 2010, a three-state degradation process of MSNs was proposed, which presented a new understanding of the degradation kinetic mechanism of MSNs that differs markedly from that of traditional non-porous silica-based materials. 55 Apart from, Lin et al. systematically shown the impact of MSNs with diverse particle size, pore structure and surface modification on hemolytic activity in 2010. 56 This pioneering work delivers advice for understanding the toxic influences of MSNs in vivo. In 2011, Cornell dots, which are silica-based hybrid NPs with a size of 6-10 nm, become the first FDA-approved nanoformulation for a first-in-human clinical trial. 57 The first-in-human clinical trial of 124 I-labelled Cornell dots showed that they can be applied to diagnose and stage tumors including melanoma and malignant brain cancer. 58 Furthermore, to obtain MSNs with rapid biodegradability, Zhao's group developed a biphase stratification method for preparing monodispersed three-dimensional dendritic MSNs (3D-dendritic MSNs). The as-prepared 3D-dendritic MSNs can degrade completely in the simulated biological medium within 24 h. 59 Over the past few years, with the outbreak and spread of coronavirus SARS-CoV-2, nanotechnology based on MSNs against coronavirus infection has also developed. In 2020, Balagna et al. conducted preliminary antiviral test toward SARS-CoV-2 by using the silver nanocluster/silica nanocomposite deposited onto facial masks. 60 In another work, a FDA-approved antiviral drug, niclosamide (NIC), was encapsulated into MSNs, followed by the coating with Tween 60. The MSNs-based nanocomposite was demonstrated to be a potential oral formulation for SARS-CoV-2. 61
What is the difference between fumed silica and precipitated silica?
silica supplier South Africa Sakamoto, Y. et al. Direct imaging of the pores and cages of three-dimensional mesoporous materials. Nature 408, 449-453 (2000). Post CAS PubMed Google Scholar
What drives silica raw material prices?
fused silica powder MSNs are chemically and biologically inert nanomaterials compared to other inorganic nanomaterials. Only a few studies have been reported on the biomedical applications based on the inherent activities of MSNs. For instance, it has been noted that the MSNs containing rich pore structure possess ultrasound-induced cavitation impact, and they exhibit sonodynamic activity by moderately modulating the surface wettability for thrombolysis therapy. 340 In addition, Si ions have been demonstrated to show some natural bioactivity in tissue engineering, and the Si ions released from the degradation of MSNs can activate the expression of bone-related genes or proteins, stimulate the cartilage differentiation, and consequently play an essential role in the formation process of bone and cartilage. 341 However, given their relatively low outcome efficiency, the current research on MSNs in the biomedical field is more focused on acting as matrix to form nanocomposites, or as nanocarriers to deliver various cargos. In this part, the diverse types of MSNs-based nanomaterials in biosensing, bioimaging, targeted disease therapy and tissue engineering will be summarized (Table 2 ).
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.